2019;8:e012356
GLP-1 Medications Linked to Increased Hair Loss in New Study Heres How Much They Raise the Risk of Alopecia Researchers at the University of Pennsylvania published their findings on Wednesday, July 22 NEED TO KNOW A study from researchers at the University of Pennsylvania found GLP-1 medications are linked to a higher risk of hair loss, primarily non-scarring alopecia Hair loss cases remain rare, with 3 to 9 per 1,000 users annually, but may impact treatment decisions GLP-1 drugs, originally for type 2 diabetes, are now also widely used for weight management and appetite control A new study has linked the use of GLP-1s with increased hair loss
Research demonstrates that stopping Tesamorelin allows visceral fat to reaccumulate, suggesting ongoing treatment is necessary for maintenance
Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-, PMN-elastase, lysozyme and neopterin
This treatment can also promote collagen production, improving skin elasticity and reducing signs of aging
For most individuals, a balanced diet provides sufficient carnitine, but specific populations may require supplementation to meet their metabolic needs